| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Intellia Therapeutics, Inc. | NTLA | Grant | | 1.7k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 2.4k | $45.20 | $110.6k | | 06/14/2023 |
| 06/26/2019 | AbbVie Inc. | ABBV | Purchase | Common Stock, $0.01 par value | 30.4k | $67.30 | $2M | | 06/26/2019 |
| 02/28/2019 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 27.3k | $79.41 | $2.2M | | 02/28/2019 |
| 02/21/2019 | AbbVie Inc. | ABBV | Grant | | 60.7k | $79.02 | $4.8M | | 02/21/2019 |
| 02/21/2019 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 8.5k | $0.00 | $0 | | 02/21/2019 |
| 02/21/2019 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 15k | $0.00 | $0 | | 02/21/2019 |
| 02/21/2019 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 15.9k | $0.00 | $0 | | 02/21/2019 |
| 02/21/2019 | AbbVie Inc. | ABBV | Grant | Common Stock, $0.01 par value | 22.2k | $0.00 | $0 | | 02/21/2019 |
| 12/12/2018 | AbbVie Inc. | ABBV | Sale | Common Stock, $0.01 par value | 60k | $90.00 | $5.4M | | 12/12/2018 |
| 03/01/2018 | AbbVie Inc. | ABBV | Exercise | | 13.4k | $28.31 | $379.4k | | 02/28/2018 |
| 03/01/2018 | AbbVie Inc. | ABBV | Exercise | | 19k | $24.21 | $460k | | 02/28/2018 |
| 03/01/2018 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 32.4k | $114.50 | $3.7M | | 02/28/2018 |
| 02/28/2018 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 38.5k | $119.44 | $4.6M | | 02/28/2018 |
| 02/28/2018 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 28.4k | $118.26 | $3.4M | | 02/28/2018 |
| 02/15/2018 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 15.9k | $0.00 | $0 | | 02/15/2018 |
| 02/15/2018 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 17.3k | $0.00 | $0 | | 02/15/2018 |
| 02/15/2018 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 15k | $0.00 | $0 | | 02/15/2018 |
| 02/15/2018 | AbbVie Inc. | ABBV | Grant | | 45.8k | $114.36 | $5.2M | | 02/15/2018 |
| 02/16/2017 | AbbVie Inc. | ABBV | Grant | | 100.1k | $61.36 | $6.1M | | 02/16/2017 |
| 02/16/2017 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 15.9k | $0.00 | $0 | | 02/16/2017 |
| 02/16/2017 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 35.4k | $0.00 | $0 | | 02/16/2017 |
| 02/29/2016 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 45.7k | $56.00 | $2.6M | | 02/29/2016 |
| 02/18/2016 | AbbVie Inc. | ABBV | Grant | | 95.4k | $54.86 | $5.2M | | 02/18/2016 |
| 02/28/2015 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 8.2k | $60.50 | $495.6k | | 02/27/2015 |
| 02/27/2015 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 10.3k | $60.52 | $623.3k | | 02/27/2015 |
| 02/19/2015 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 56k | $0.00 | $0 | | 02/19/2015 |
| 02/19/2015 | AbbVie Inc. | ABBV | Grant | | 110.8k | $58.88 | $6.5M | | 02/19/2015 |
| 12/22/2014 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 8.5k | $68.00 | $577.7k | | 12/22/2014 |
| 12/22/2014 | AbbVie Inc. | ABBV | Exercise | Option (right to buy) | 8.5k | $24.07 | $204.5k | | 12/22/2014 |
| 03/03/2014 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 2.4k | $50.19 | $122.9k | | 02/28/2014 |
| 03/03/2014 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 1.4k | $50.19 | $70.3k | | 02/28/2014 |
| 03/03/2014 | AbbVie Inc. | ABBV | Sale | Common stock, $0.01 par value | 100 | $51.20 | $5.1k | | 02/28/2014 |
| 02/28/2014 | AbbVie Inc. | ABBV | Payment of Exercise | Common stock, $0.01 par value | 9.9k | $51.91 | $512.5k | | 02/28/2014 |
| 02/20/2014 | AbbVie Inc. | ABBV | Grant | Common stock, $0.01 par value | 53.8k | $0.00 | $0 | | 02/20/2014 |
|